MODERATE TO SEVERE ASTHMA
Clinical trials for MODERATE TO SEVERE ASTHMA explained in plain language.
Never miss a new study
Get alerted when new MODERATE TO SEVERE ASTHMA trials appear
Sign up with your email to follow new studies for MODERATE TO SEVERE ASTHMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New asthma drug shows promise in early trial for better breathing
Disease control Not yet recruitingThis study tests a new drug called linvemastat for adults with moderate-to-severe asthma that is not fully controlled by standard inhalers. The drug targets lung inflammation to improve breathing and reduce asthma attacks. About 135 participants will receive either linvemastat or…
Matched conditions: MODERATE TO SEVERE ASTHMA
Phase: PHASE2 • Sponsor: Foresee Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 05:53 UTC
-
New asthma injection shows promise in Mid-Stage trial
Disease control Not yet recruitingThis study tests an investigational drug called RC1416 in 195 adults with moderate to severe asthma that is not well controlled. The goal is to see if the injection improves lung function and reduces asthma attacks compared to a placebo. Participants must be 18-75 years old, have…
Matched conditions: MODERATE TO SEVERE ASTHMA
Phase: PHASE2 • Sponsor: Nanjing RegeneCore Biotech Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 05:46 UTC